4//SEC Filing
AtriCure, Inc. 4
Accession 0001209191-17-022088
$ATRCCIK 0001323885operating
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 5:22 PM ET
Size
9.0 KB
Accession
0001209191-17-022088
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
LUX ANDREW L
V.P. & Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2017-03-17$6.27/sh+20,000$125,400→ 85,589 total - Sale
Common Stock
2017-03-17$18.85/sh−20,000$377,000→ 65,589 total - Exercise/Conversion
Stock Option (right to buy)
2017-03-17−20,000→ 0 totalExercise: $6.27From: 2013-10-25Exp: 2022-10-25→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $18.64 to $18.99 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]These options were granted on October 25, 2012 and are exercisable as to 25% of the shares upon the one-year anniversary of the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001323885
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 5:22 PM ET
- Size
- 9.0 KB